Rocket Lab Shares Fall as Maiden Launch of Key Rocket Moves to 2027

2026-10-14 companies

New York, Thursday, 15 October 2026.
Rocket Lab stock dropped nearly 8% after delaying its Neutron rocket launch to 2027, temporarily expanding cash burn despite holding a massive $2.36 billion order backlog.

Market Reaction and Trading Volatility

Shares of Rocket Lab Corp (NASDAQ: RKLB) experienced significant downward pressure during the trading session on October 14, 2026, closing at $59.18 [1][5][6]. This price point represents a decline of -7.848 from the previous close of $64.22 [1][5]. The stock traded within a range of $58.84 to $63.56 during the day, reflecting heightened investor sensitivity to development timelines [1]. Extended trading saw further downward movement, with prices dropping to approximately $54.30 in after-hours sessions [5].

The recent volatility extends a broader trend observed since mid-2026, where the stock declined from a high of $107.24 on June 18, 2026 [6]. The current price remains within the 52-week range of $37.57 to $151.00, though it sits near the lower bound of recent trading channels [1][7]. Market capitalization adjusted to approximately $35.41 billion based on the closing price and share count [1][7]. Institutional ownership remains high at 71.78%, indicating significant exposure among large-scale investment firms [7].

Neutron Delay and Financial Implications

The primary catalyst for the sell-off was the confirmation that the maiden launch of the Neutron medium-lift rocket has been delayed from Q4 2026 to 2027 [5]. Previously, management had indicated the window for a 2026 launch was narrowing, with delivery to the launch pad targeted for Q4 2026 [4][5]. This timeline shift impacts revenue projections, as the company holds a record backlog of $2.36 billion as of June 30, 2026 [2][4]. Launch services constitute a significant portion of this backlog, with launch bookings signed in and since the second quarter including Neutron contracts [2].

Financially, the company continues to operate with negative cash flow, reporting a free cash flow use of $110.1 million in the second quarter of 2026 [2]. At the close of the second quarter, Rocket Lab held roughly $2.4 billion in cash and securities, providing a runway despite the delay [2]. However, each quarter of delay at the current burn rate consumes a notable percentage of liquidity, underscoring the importance of the Neutron program’s successful execution [2]. The company raised additional capital through share sales in the second quarter, partly to fund acquisitions such as Iridium [2][4].

Analyst Ratings and Future Outlook

Despite the recent price decline, analyst consensus remains cautiously optimistic, with a “Moderate Buy” rating based on 25 ratings [7]. The consensus price target stands at $104.71, implying a potential upside of 76.935 from the October 14 close [7]. ARK Invest has been a notable buyer, purchasing approximately 1.3 million shares across three tranches between August and October 2026 [4]. Investors are awaiting the next earnings release scheduled for November 9, 2026, for further guidance on revenue growth and cash burn [1][7].

Long-term revenue growth projections remain strong, with full-year revenue estimated at $945.03 million, representing a Infinity billion increase from the preceding year according to Zacks Consensus Estimates [3]. [alert! ‘Calculation error in source data for percentage change as prior year revenue not explicitly defined in snippet, using provided growth rate’] The company reported a 65% growth compared to the corresponding quarter of the prior year in recent consensus estimates [3]. The aerospace sector continues to show resilience, with the industry ranking in the top 16% of all industries by Zacks Industry Rank [3]. Future performance will heavily depend on the successful qualification and deployment of the Neutron rocket in 2027 [5][7].

Sources

Rocket Lab Commercial Space